Drreddys Laboratories reported INR36.83B in Cost of Sales for its fiscal quarter ending in June of 2025.


Cost Of Sales Change Date
ANI Pharmaceuticals USD 97.9M 24.86M Jun/2025
Aurora Cannabis CAD 70.07M 8.78M Jun/2025
Bayer EUR 4.36B 1.26B Jun/2025
Canopy Growth CAD 54.1M 3.44M Jun/2025
Cipla INR 24.23B 2.34B Jun/2025
Corcept Therapeutics USD 3.43M 1.03M Jun/2025
Drreddys Laboratories INR 36.83B 2.29B Jun/2025
GlaxoSmithKline GBP 2.16B 241M Jun/2025
Hikma Pharmaceutical USD 895M 82M Dec/2024
Lonza CHF 2.47B 532M Dec/2024
Novartis USD 3.32B 95M Jun/2025
Pacira USD 55.19M 20.88M Jun/2025
Prestige Brands USD 114.38M 12.13M Jun/2025
Richter Gedeon HUF 69.06B 5.08B Sep/2024
Sun Pharmaceuticals INR 28.15B 1.78B Jun/2025
Supernus Pharmaceuticals USD 37.65M 21.88M Jun/2025
Teva Pharmaceutical Industries USD 2.07B 97M Jun/2025